netFormulary NHS
Sunderland Joint Formulary
NHS Sunderland Clinical Commissioning Group
South Tyneside and Sunderland NHS Foundation Trust
 Search
 Formulary Chapter 7: Obstetrics, Gynaecology, and urinary-tract disorders - Full Chapter
07.03.01  Expand sub section  Combined hormonal contraceptives
Rigevidon®
View adult BNF View SPC online
First Choice

Tablets: Ethinylestradiol 30mcg / levonorgestrel 150mcg

 
Cilique®
View adult BNF View SPC online
Alternatives

Tablets: Ethinylestradiol 35 mcg / norgestimate 250 mcg

 
   
Gedarel 30/150 ®
View adult BNF View SPC online
Alternatives

Tablets: Ethinylestradiol 30mcg / desogestrel 150mcg

 
   
Lucette®
View adult BNF View SPC online
Alternatives

Tablets: Ethinylestradiol 30 mcg / drospirenone 3 mg

 
   
Millinette 30/75 ®
View adult BNF View SPC online
Alternatives

Tablets: Ethinylestradiol 30mcg / gestodene 75 mcg

 
   
Brevinor®
View adult BNF View SPC online
Alternatives

Tablets: ethinylestradiol 35 microgram/norethisterone 500 microgram

 
   
Cilest®
View adult BNF View SPC online
Alternatives

Tablets: Ethinylestradiol 35 mcg / norgestimate 250 mcg

 
   
Femodene®
View adult BNF View SPC online
Alternatives

Tablets: Ethinylestradiol 30mcg / gestodene 75 mcg

 
   
Femodene® ED
View adult BNF View SPC online
Alternatives

Tablets: Ethinylestradiol 30mcg / gestodene 75 mcg

 
   
Levest®
View adult BNF View SPC online
Alternatives

Tablets: Ethinylestradiol 30micrograms/ norgestimate 150 micrograms

 
   
Lizinna®
View adult BNF View SPC online
Alternatives

Tablets: Ethinylestradiol 35micrograms/ norgestimate 250 micrograms

 
   
Loestrin 30®
View adult BNF View SPC online
Alternatives

Tablets: Ethinylestradiol 30 micrograms / norethisterone 1.5mg

 
   
Maexeni ®
View adult BNF View SPC online
Alternatives

Tablets: Ethinylestradiol 30 microgram/levonorgestrel 150 microgram

 
   
Marvelon 30/150 ®
View adult BNF View SPC online
Alternatives

Tablets: Ethinylestradiol 30mcg / desogestrel 150mcg

 
   
Microgynon 30®
View adult BNF View SPC online
Alternatives

Tablets: Ethinylestradiol 30mcg / levonorgestrel 150mcg

 
   
Microgynon ED ®
View adult BNF View SPC online
Alternatives

Tablets: Ethinylestradiol 30mcg / levonorgestrel 150mcg

 
   
Ovranette®
View adult BNF View SPC online
Alternatives

Tablets: 150 micrograms levonorgestrel and 30 micrograms ethinylestradiol

 
   
Ovysmen®
View adult BNF View SPC online
Alternatives

Tablets: Ethinylestradiol 35 mcg / norethiserone 500mcg

 
   
Yasmin®
View adult BNF View SPC online
Alternatives

Tablets: ethinylestradiol 30 microgram/drospirenone 3mg

 
   
07.03.01  Expand sub section  Emergency contraception
07.03.01.02  Expand sub section  Co-cyprindiol
Co-cyprindiol 2000/35
View adult BNF View SPC online
Formulary

Tablets: Ethinyllestradiol 35 micrograms/ cyprioterone 2mg

 
   
07.03.01.03  Expand sub section  Phased formulations
Tri-regol®
View adult BNF View SPC online
Formulary

Tablets

 
   
Logynon®
View adult BNF View SPC online
Formulary

Tablets

 
   
Logynon® ED
View adult BNF View SPC online
Formulary

Tablets

 
   
07.03.01.04  Expand sub section  Low dose oestrogen – 20 microgram ethinylestradiol to top
Femodette®
View adult BNF View SPC online
Formulary

Tablets: Ethinylestradiol 20mcg / gestodene 75 mcg

 
   
Gedarel 20/150 ®
View adult BNF View SPC online
Formulary

Tablets: Ethinylestradiol 20mcg / desogestrel 150mcg

 
   
Loestrin 20®
View adult BNF View SPC online
Formulary

Tablets: Ethinylestradiol 20 mcg / norethisterone 1.5mg

 
   
Mercilon®
View adult BNF View SPC online
Formulary

Tablets: Ethinylestradiol 20mcg / desogestrel 150mcg

 
   
Millinette 20/75 ®
View adult BNF View SPC online
Formulary

Tablets: Ethinylestradiol 20mcg / gestodene 75 mcg

 
   
07.03.01.05  Expand sub section  Transdermal (standard strength)
Evra®
View adult BNF View SPC online
Formulary

*Self adhesive patches releasing approximately 20 micrograms ethinylestradiol and 150 micrograms norelgestromin /24hours


 


*For use in a small number of women with gastrointestinal absorption problems or with compliance issues

 
   
07.03.01.06  Expand sub section  Vaginal rings (low strength
NuvaRing®
View adult BNF View SPC online
Formulary
Green +

Vaginal ring releasing ethinylestradiol approximately 15 micrograms/24hours and etonogestrel approximately 120 micrograms/24hours

 
   
07.03.01.07  Expand sub section  Copper intra-uterine devices
TT 380 Slimline®
View adult BNF View SPC online
First Choice

Intrauterine device - replacement every 10 years

 
Mini TT 380 Slimline®
View adult BNF View SPC online
First Choice

Intrauterine device - replacement every 5 years

 
T-Safe® Cu 380 A
View adult BNF View SPC online
First Choice

Intrauterine device - replacement every 10 years

 
Nova T 380®
View adult BNF View SPC online
Alternatives

Intrauterine device - replacement every 5 years

 
   
 ....
 Non Formulary Items
Combined Hormonal Contraceptives  (BiNovum®)

View adult BNF View SPC online
Non Formulary
 
Combined Hormonal Contraceptives  (Minulet®)

View adult BNF View SPC online
Non Formulary
 
Combined Hormonal Contraceptives  (Norinyl-1®)

View adult BNF View SPC online
Non Formulary
 
Combined Hormonal Contraceptives  (Qlaira®)

View adult BNF View SPC online
Non Formulary
 
Combined Hormonal Contraceptives  (Synphase®)

View adult BNF View SPC online
Non Formulary
 
Combined Hormonal Contraceptives  (Triadene®)

View adult BNF View SPC online
Non Formulary
 
Combined Hormonal Contraceptives  (Tri-minulet®)

View adult BNF View SPC online
Non Formulary
 
Combined Hormonal Contraceptives  (Trinordiol®)

View adult BNF View SPC online
Non Formulary
 
Combined Hormonal Contraceptives  (TriNovum®)

View adult BNF View SPC online
Non Formulary
 
Ethinylestradiol 20 mcg / drospirenone 3 mg  (Eloine®)

View adult BNF View SPC online
Non Formulary
 
Ethinylestradiol 20mcg / desogestrel 150mcg  (Alenini®)

View adult BNF View SPC online
Non Formulary
 
Ethinylestradiol 30 mcg /desogestrel 150 mcg  (Cimizt®)

View adult BNF View SPC online
Non Formulary
 
Ethinylestradiol 35 mcg / noresthisterone 1mg  (Norimin®)

View adult BNF View SPC online
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Drugs for hospital use or use by a specialist within specialist centre only. Initiation and monitoring of treatment should remain under the total responsibility of the appropriate hospital clinician or specialist. These drugs should only be prescribed under the direct supervision of that clinician or specialist and are not suitable for shared care arrangements. The drug should be supplied via the hospital or specialist centre for the duration of treatment.   

Amber

These are specialist drugs which must be initiated by secondary care specialist prescribers, but with the potential to transfer prescribing to primary care within written and agreed shared care protocols and according to the agreed process for transfer of care. For these drugs, in order to ensure patient safety, some aspects of care must remain with the specialist due to their complexity e.g. monitoring of disease or drug response. Other more routine aspects can be transferred to the GP e.g. monitoring of adverse effects and supply of the medicine. The specific responsibilities of the specialist and GP are defined in the shared care agreement for each drug. Shared care agreements are still under development for some amber drugs. Until these are available, it would be expected that any shared care request from secondary care to a GP would be accompanied by written information which defines prescribing and monitoring responsibilities. The hospital specialist should also provide the GP with enough information and support to allow the safe transfer and ongoing management of prescribing into primary care.   

Green +

Drugs which should usually be initiated in secondary care, or by a specialist clinician, but can be safely maintained in primary care with very little or no monitoring required. In some cases there may be a further restriction for use outlined - these will be defined in each case.  

Green

These are defined as new and established drugs, which may be prescribed, initiated, changed or maintained on FP10 by the GP and, if appropriate, discontinued without recourse to secondary care. N.B. DRUGS NOT IDENTIFIED IN THE FORMULARY BY A RED, AMBER OR GREEN+ SYMBOL ARE CLASSIFIED AS GREEN.   

netFormulary